FOREBYG HPV-relaterede kræftformer (PREVENT)
1. maj 2025 opdateret af: University of Utah
FOREBYG: Praksisbaserede tilgange til at fremme HPV-vaccination i sikkerhedsnettet
Denne undersøgelse vil tjene som en af de første til at udvikle og teste effektiviteten af strategier til at fremme HPV-vaccination blandt forskellige landlige forældre og omsorgspersoner til børn i alderen 9-17 år i Mountain West.
Når først implementeret i praksis, kan vores intervention betydeligt reducere forskellene i byrden af HPV-associerede kræftformer blandt landbefolkninger i USA.
Den foreslåede undersøgelse vil vurdere effektiviteten af klinikbaseret outreach for at øge vaccinationsraten for HPV på fire samfundsklinikker i landdistrikterne i Washington.
Den foreslåede undersøgelse omfatter følgende: (1) bootcamp-oversættelse til skræddersyet meddelelser baseret på input fra patient og udbyder; (2) FOREBYG randomiseret kontrolleret forsøg (RCT), der vil tildele voksne forældre/plejer deltagere til en tidslinje for modtagelse af intervention; og (3) kvalitative interviews med forældre/plejere, udbydere og andre sundhedsfaglige teammedlemmer og udvikling af bedste praksis, implementeringsvejledninger og formidling af resultater for andre klinikker til at implementere programmet i en bredere skala.
Ved afslutningen af forsøget vil der blive gennemført personlige interviews med forældre/plejere, klinisk personale og udbydere for at forstå reaktioner på programmet og vedvarende barrierer for at påbegynde og fuldføre HPV-vaccination.
Studieoversigt
Status
Afsluttet
Intervention / Behandling
Detaljeret beskrivelse
Det kliniske forsøg i PREVENT-studiet er et patient-randomiseret kontrolforsøg (RCT) af to human papillomavirus (HPV) vaccinationspatientpåmindelsesinterventionsarme, som vil finde sted i landdistriktsklinikker, der drives af Sea Mar Community Health Centres. Resultaterne fra BootCamp Translation (BCT) aktiviteterne vil blive udført på engelsk og spansk og vil informere PREVENT RCT udvikling og meddelelsesstrategier; BCT-aktiviteter er ikke en del af RCT.
PREVENT RCT vil administrere et randomiseret kontrolleret tre-arms patientforsøg, der vil vurdere færdiggørelsen af den næste nødvendige dosis af HPV-vaccination og rettidig afslutning af multi-dosis HPV-vaccineserien. Studiearmene for hvert forsøg vil bestå af automatiserede påmindelser, automatiske plus live-påmindelser og sædvanlig pleje. Forældre/plejere til børn og unge, der er udvalgt til forsøget, vil blive valgt ud fra etablerede undersøgelseskriterier, der anvendes på de elektroniske sundhedsjournaler, der er knyttet til statslige immuniseringsregistre. Som en minimal-risiko undersøgelse, kun for interventionen, vil efterforskerne ansøge om et frafald af informeret samtykke. RCT vil blive leveret som en del af standardbehandling, og patienter vil være uvidende om, at de er i forsøget. Leverede vaccinationsmeddelelser vil omfatte fravalgsvalg som anvist af BCT-aktiviteter og lokale politikker.
Afhængigt af de specifikke interventioner, der er defineret under BCT, vil forældre/plejere (P/C) for børn og unge (C/A) få tilsendt et vilkårligt antal påmindelser for at opmuntre forældre til at få en HPV-vaccine til deres aldersberettigede C/A. Påmindelser kan omfatte tekstbeskeder, automatiske telefonopkald, postede breve, liveopkald eller patientnavigation. Påmindelser vil blive leveret af en leverandør (automatiserede påmindelser) eller klinikpersonale (live påmindelser). Påmindelser vil blive leveret på engelsk og spansk, og tolketjenester kan bruges til live-påmindelser til den lille del af patienter, der taler andre sprog end engelsk eller spansk. Efterforskerne vil bruge elektroniske patientjournaldata til at dokumentere HPV-vaccinationshændelser som vores primære resultat af interesse. Investigatorerne vil også vurdere rækkevidden for hver interventionskomponent, defineret som andelen af patienter, der modtager en given interventionskomponent. Efterforskerne vil også vurdere forpassede muligheder, defineret som andelen af patienter, der modtager andre anbefalede vacciner (f.eks. Tdap eller meningokok), men ikke HPV, for hver undersøgelsesarm, under undersøgelsen. Mål 3 vil indsamle kvalitative data på patient- og udbyderniveau for at vurdere reaktion på programmet, faktorer forbundet med implementering og langsigtet bæredygtighed og muligheder for yderligere klinikbaserede interventioner. Under aktiv rekruttering af undersøgelser vil efterforskerne indkalde til et møde i vores datasikkerhedsmonitor bestyrelse hvert halve år. Efterforskerne vil formidle undersøgelsesresultater og forskningsprodukter i overensstemmelse med vores formidlingsplan. Resultaterne af undersøgelsen vil tjene som grundlag for et større multi-level forsøg med HPV-vaccination i landdistrikter.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
18
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Washington
-
Seattle, Washington, Forenede Stater, 98108
- Sea Mar Community Health Centers
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ja
Beskrivelse
Inklusionskriterier:
- Forældre/omsorgspersoner (P/C) til børn/unge (C/A) i alderen 9-17 år (dvs. aldersberettiget til HPV-vaccination);
- P/C med aktive klinikpatienter (dvs. er set i klinikken inden for de sidste 12 måneder); og
- P/C, der taler enten engelsk eller spansk.
Ekskluderingskriterier:
- P/C for C/A med tidligere eksklusiv HPV-vaccinationshistorie (f.eks. afsluttet vaccination eller ikke forfalden);
- P/C for C/A med kliniske tilstande, der påvirker CDC HPV-vaccinationsanbefalingerne (f.eks. graviditet);
- P/C af C/A med andre faktorer, der ville påvirke CDC HPV-anbefalinger; og
- P/C, der ikke taler spansk eller engelsk.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Engelsk sprogsession og beskeder
Den personlige eller levende Zoom-præsentation på engelsk vil bestå af en ekspertpræsentation om forskningen i sikkerheden og effektiviteten af HPV-vaccinen og sociale normer om vaccination. I denne session vil deltagerne modtage opdateret bevis på effektiv meddelelse fra klinikere (f.eks. brug af formodede udsagn, bundtning af HPV-vaccineanbefalinger med anbefalinger til andre vacciner) ud over nye formater for pædagogiske meddelelser (f.eks. digitale videoer, fortællinger) ). Deltagere i den engelsksprogede tekstbeskedgruppe vil give iterativ feedback til forskerholdet om HPV-vaccinationsbeskeder over en 3-måneders periode. |
Bootcamp Translation (BCT), en metode til at engagere forskellige interessenter i en konsensusopbygningsproces, er blevet brugt af dette forskerhold til aktivt at udvikle og tilpasse undersøgelsesinterventioner. Den bruger en iterativ, fleksibel tidsplan med ansigt-til-ansigt møder kombineret med korte, fokuserede telekonferencer. BCT understreger ingen forkerte svar og intet ekspertisehierarki. Processen kræver op til ni (9) timers deltagertid over 3-6 måneder. Deltagerne vil blive undersøgt før og efter den personlige session for at vurdere læringsresultater og indfange grundlæggende sociodemografisk information. BCT-processen vil definere formatet (tilstand og frekvens) og indholdet af meddelelser for at fremme færdiggørelsen af vaccineserier. Auto- og Auto-Plus-interventionsarme kan bruge nogle af de samme komponenter (automatiske opkald, liveopkald, tekstbeskeder, e-mails og mails). |
|
Eksperimentel: Spansk sprogsession og meddelelser
Den personlige eller live Zoom-præsentation på spansk vil bestå af en ekspertpræsentation om forskningen i sikkerheden og effektiviteten af HPV-vaccinen og sociale normer om vaccination. I denne session vil deltagerne modtage opdateret bevis på effektiv meddelelse fra klinikere (f.eks. brug af formodede udsagn, bundtning af HPV-vaccineanbefalinger med anbefalinger til andre vacciner) ud over nye formater for pædagogiske meddelelser (f.eks. digitale videoer, fortællinger) ). Deltagere i den spansksprogede SMS-gruppe vil give iterativ feedback til forskerholdet om HPV-vaccinationsbeskeder over en 3-måneders periode. |
Bootcamp Translation (BCT), en metode til at engagere forskellige interessenter i en konsensusopbygningsproces, er blevet brugt af dette forskerhold til aktivt at udvikle og tilpasse undersøgelsesinterventioner. Den bruger en iterativ, fleksibel tidsplan med ansigt-til-ansigt møder kombineret med korte, fokuserede telekonferencer. BCT understreger ingen forkerte svar og intet ekspertisehierarki. Processen kræver op til ni (9) timers deltagertid over 3-6 måneder. Deltagerne vil blive undersøgt før og efter den personlige session for at vurdere læringsresultater og indfange grundlæggende sociodemografisk information. BCT-processen vil definere formatet (tilstand og frekvens) og indholdet af meddelelser for at fremme færdiggørelsen af vaccineserier. Auto- og Auto-Plus-interventionsarme kan bruge nogle af de samme komponenter (automatiske opkald, liveopkald, tekstbeskeder, e-mails og mails). |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Antal forældre, der deltager i BCT
Tidsramme: 1 dag efter studieoptagelse
|
Dette resultatmål vil rapportere antallet af deltagere, der deltager i BCT-sessionerne på engelsk, og antallet af deltagere, der deltager i BCT-spansk-sessionerne. BCT er en samfundsbaseret forskningstilgang til at udvikle og evaluere beskeder til sundhedsrelaterede problemer. Denne undersøgelse vil anvende BCT til at bestemme hyppigheden og indholdet af HPV-meddelelser til fremtidig forskning. |
1 dag efter studieoptagelse
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Sandsynlighed for forældre til at få HPV -vaccination for deres barn (REN) i år
Tidsramme: Efter den personlige session (1 dag)
|
Deltagerne vil blive undersøgt før og efter den personlige session for at vurdere læringsresultater. Dette resultatmål er en selvrapportering med en enkelt genstand for forældrenes intention om at få HPV-vaccination for deres børn i år. En lav score (minimum: 1 ekstremt usandsynlig) er et ugunstigt resultat, og en høj score (maksimalt: 5 ekstremt sandsynligt) er et gunstigt resultat. Dette resultatmål rapporterer antallet af patienter pr. Respons for BCT -engelske sessioner og BCT -spanske sessioner. |
Efter den personlige session (1 dag)
|
|
Tilfredshed med BCT -session
Tidsramme: Efter den personlige session (1 dag)
|
Deltagerne vil blive undersøgt før og efter den personlige session for at vurdere læringsresultater. Dette resultatforanstaltning er en selvrapportering af deltagernes tilfredshed med BCT-sessionen. En lav score (minimum: 1 slet ikke tilfreds) er et ugunstigt resultat, og en høj score (maksimal: 10 ekstremt tilfreds) er et gunstigt resultat. Dette resultatmål vil rapportere den gennemsnitlige score for deltagere for BCT English Sessions og BCT -spanske sessioner. |
Efter den personlige session (1 dag)
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Deanna Kepka, PhD, MPH, Huntsman Cancer Institute/ University of Utah
- Studiestol: Medical Director, MD, Sea Mar
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Warner EL, Ding Q, Pappas L, Bodson J, Fowler B, Mooney R, Kirchhoff AC, Kepka D. Health Care Providers' Knowledge of HPV Vaccination, Barriers, and Strategies in a State With Low HPV Vaccine Receipt: Mixed-Methods Study. JMIR Cancer. 2017 Aug 11;3(2):e12. doi: 10.2196/cancer.7345.
- Bruno DM, Wilson TE, Gany F, Aragones A. Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations. Vaccine. 2014 Jul 16;32(33):4149-54. doi: 10.1016/j.vaccine.2014.05.058. Epub 2014 Jun 2.
- Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014 Jan;168(1):76-82. doi: 10.1001/jamapediatrics.2013.2752.
- Malterud K, Siersma VD, Guassora AD. Sample Size in Qualitative Interview Studies: Guided by Information Power. Qual Health Res. 2016 Nov;26(13):1753-1760. doi: 10.1177/1049732315617444. Epub 2016 Jul 10.
- Glasgow RE, Klesges LM, Dzewaltowski DA, Bull SS, Estabrooks P. The future of health behavior change research: what is needed to improve translation of research into health promotion practice? Ann Behav Med. 2004 Feb;27(1):3-12. doi: 10.1207/s15324796abm2701_2.
- Henley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC. Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States. MMWR Surveill Summ. 2017 Jul 7;66(14):1-13. doi: 10.15585/mmwr.ss6614a1.
- Fu LY, Bonhomme LA, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine. 2014 Apr 7;32(17):1901-20. doi: 10.1016/j.vaccine.2014.01.091. Epub 2014 Feb 14.
- Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010 Feb 1;116(3):544-73. doi: 10.1002/cncr.24760.
- Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care. 2005 May;43(5):436-44. doi: 10.1097/01.mlr.0000160375.47920.8c.
- Kepka D, Spigarelli MG, Warner EL, Yoneoka Y, McConnell N, Balch A. Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data. Papillomavirus Res. 2016 Dec;2:128-132. doi: 10.1016/j.pvr.2016.06.002.
- Katz ML, Reiter PL, Heaner S, Ruffin MT, Post DM, Paskett ED. Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine. 2009 Jun 19;27(30):3945-52. doi: 10.1016/j.vaccine.2009.04.040. Epub 2009 May 3.
- Maneesriwongul W, Dixon JK. Instrument translation process: a methods review. J Adv Nurs. 2004 Oct;48(2):175-86. doi: 10.1111/j.1365-2648.2004.03185.x.
- Glasgow RE, Klesges LM, Dzewaltowski DA, Estabrooks PA, Vogt TM. Evaluating the impact of health promotion programs: using the RE-AIM framework to form summary measures for decision making involving complex issues. Health Educ Res. 2006 Oct;21(5):688-94. doi: 10.1093/her/cyl081. Epub 2006 Aug 31.
- Glasgow RE. RE-AIMing research for application: ways to improve evidence for family medicine. J Am Board Fam Med. 2006 Jan-Feb;19(1):11-9. doi: 10.3122/jabfm.19.1.11.
- Shea CM, Jacobs SR, Esserman DA, Bruce K, Weiner BJ. Organizational readiness for implementing change: a psychometric assessment of a new measure. Implement Sci. 2014 Jan 10;9:7. doi: 10.1186/1748-5908-9-7.
- Moorhead SA, Hazlett DE, Harrison L, Carroll JK, Irwin A, Hoving C. A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res. 2013 Apr 23;15(4):e85. doi: 10.2196/jmir.1933.
- Coronado GD, Burdick T, Petrik A, Kapka T, Retecki S, Green B. Using an Automated Data-driven, EHR-Embedded Program for Mailing FIT kits: Lessons from the STOP CRC Pilot Study. J Gen Pract (Los Angel). 2014 Jan 5;2:1000141. doi: 10.4172/2329-9126.1000141.
- Bartholomew LK, Parcel GS, Kok G. Intervention mapping: a process for developing theory- and evidence-based health education programs. Health Educ Behav. 1998 Oct;25(5):545-63. doi: 10.1177/109019819802500502.
- undefined
- Saslow D, Andrews KS, Manassaram-Baptiste D, Loomer L, Lam KE, Fisher-Borne M, Smith RA, Fontham ET; American Cancer Society Guideline Development Group. Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement. CA Cancer J Clin. 2016 Sep;66(5):375-85. doi: 10.3322/caac.21355. Epub 2016 Jul 19.
- Tabak RG, Duggan K, Smith C, Aisaka K, Moreland-Russell S, Brownson RC. Assessing Capacity for Sustainability of Effective Programs and Policies in Local Health Departments. J Public Health Manag Pract. 2016 Mar-Apr;22(2):129-37. doi: 10.1097/PHH.0000000000000254.
- Brownson RC, Reis RS, Allen P, Duggan K, Fields R, Stamatakis KA, Erwin PC. Understanding administrative evidence-based practices: findings from a survey of local health department leaders. Am J Prev Med. 2014 Jan;46(1):49-57. doi: 10.1016/j.amepre.2013.08.013.
- Wutich A, Bernard HR. Sharing qualitative data & analysis. With whom and how widely?: A response to 'Promises and pitfalls of data sharing in qualitative research'. Soc Sci Med. 2016 Nov;169:199-200. doi: 10.1016/j.socscimed.2016.09.041. Epub 2016 Sep 30. No abstract available.
- Patton MQ. Qualitative research and evaluation methods. Thousand Oaks, CA: Sage Publications, Inc.; 2002
- Silverman D. Qualitative Research: A practical handbook. Thousand Oaks, CA: Sage Publications, Inc.; 2010.
- Nonzee NJ, Baldwin SB, Cui Y, Singhal R. Disparities in parental human papillomavirus (HPV) vaccine awareness and uptake among adolescents. Vaccine. 2018 Feb 28;36(10):1243-1247. doi: 10.1016/j.vaccine.2017.08.046. Epub 2017 Sep 28.
- Choi Y, Eworuke E, Segal R. What explains the different rates of human papillomavirus vaccination among adolescent males and females in the United States? Papillomavirus Res. 2016 Dec;2:46-51. doi: 10.1016/j.pvr.2016.02.001. Epub 2016 Mar 4.
- Garcia AA, Zuniga JA, Lagon C. A Personal Touch: The Most Important Strategy for Recruiting Latino Research Participants. J Transcult Nurs. 2017 Jul;28(4):342-347. doi: 10.1177/1043659616644958. Epub 2016 Apr 25.
- Kim SY, Chen S, Hou Y, Zeiders KH, Calzada EJ. Parental socialization profiles in Mexican-origin families: Considering cultural socialization and general parenting practices. Cultur Divers Ethnic Minor Psychol. 2019 Jul;25(3):439-450. doi: 10.1037/cdp0000234. Epub 2018 Nov 1.
- Coronado GD, Petrik A, Spofford M, Talbot J, Do HH, Sanchez J, Kapka T, Taylor V. Perceptions of under and overutilization of cervical cancer screening services at Latino-serving community health centers. J Community Health. 2013 Oct;38(5):915-8. doi: 10.1007/s10900-013-9701-1.
- Jackson ML, Henrikson NB, Grossman DC. Evaluating Washington State's immunization information system as a research tool. Acad Pediatr. 2014 Jan-Feb;14(1):71-6. doi: 10.1016/j.acap.2013.10.002.
- Centers for Disease Control and Prevention. Human Papillomavirus (HPV). Educational Materials. Available from: https://www.cdc.gov/hpv/hcp/educational-materials.html.
- Pew Research Center. Mobile Fact Sheet. Available from: https://www.pewresearch.org/internet/fact-sheet/mobile/
- Tiro JA, Sanders JM, Pruitt SL, Stevens CF, Skinner CS, Bishop WP, Fuller S, Persaud D. Promoting HPV Vaccination in Safety-Net Clinics: A Randomized Trial. Pediatrics. 2015 Nov;136(5):850-9. doi: 10.1542/peds.2015-1563. Epub 2015 Oct 19.
- Calo WA, Gilkey MB, Malo TL, Robichaud M, Brewer NT. A content analysis of HPV vaccination messages available online. Vaccine. 2018 Nov 26;36(49):7525-7529. doi: 10.1016/j.vaccine.2018.10.053. Epub 2018 Oct 23.
- Nan X, Madden K, Richards A, Holt C, Wang MQ, Tracy K. Message Framing, Perceived Susceptibility, and Intentions to Vaccinate Children Against HPV Among African American Parents. Health Commun. 2016 Jul;31(7):798-805. doi: 10.1080/10410236.2015.1005280. Epub 2015 Dec 8.
- Mroz S, Zhang X, Williams M, Conlon A, LoConte NK. Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015. Prev Chronic Dis. 2017 Sep 28;14:E85. doi: 10.5888/pcd14.160610.
- Thompson JH, Davis MM, Michaels L, Rivelli JS, Castillo ML, Younger BM, Castro M, Reich SL, Coronado GD. Developing Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program in a Latino-Based Community Health Center. J Am Board Fam Med. 2019 May-Jun;32(3):307-317. doi: 10.3122/jabfm.2019.03.180026.
- National Heart Lung and Blood Institute. Research dissemination and implementation (R18) grants2011 01/09/2012. Available from: http://www.nhlbi.nih.gov/funding/policies/dissemination&implementationR18.htm.
- Glasgow RE, Ory MG, Klesges LM, Cifuentes M, Fernald DH, Green LA. Practical and relevant self-report measures of patient health behaviors for primary care research. Ann Fam Med. 2005 Jan-Feb;3(1):73-81. doi: 10.1370/afm.261.
- National Cancer Institute. How do RE-AIM elements relate to planning? 2011 01/05/2012. Available from: http://cancercontrol.cancer.gov/IS/reaim/faq.html#define.
- Thompson JH, Davis MM, Leo MC, Schneider JL, Smith DH, Petrik AF, Castillo M, Younger B, Coronado GD. Participatory Research to Advance Colon Cancer Prevention (PROMPT): Study protocol for a pragmatic trial. Contemp Clin Trials. 2018 Apr;67:11-15. doi: 10.1016/j.cct.2018.02.001. Epub 2018 Feb 9.
- Westfall JM, Zittleman L, Sutter C, Emsermann CB, Staton EW, Van Vorst R, Dickinson LM; Community Advisory Council. Testing to prevent colon cancer: results from a rural community intervention. Ann Fam Med. 2013 Nov-Dec;11(6):500-7. doi: 10.1370/afm.1582.
- Norman N, Bennett C, Cowart S, Felzien M, Flores M, Flores R, Haynes C, Hernandez M, Rodriquez MP, Sanchez N, Sanchez S, Winkelman K, Winkelman S, Zittleman L, Westfall JM. Boot camp translation: a method for building a community of solution. J Am Board Fam Med. 2013 May-Jun;26(3):254-63. doi: 10.3122/jabfm.2013.03.120253.
- Satcher, D. (2005). Methods in community-based participatory research for health. John Wiley & Sons.
- SeaMar Community Health Centers (Clinica de la Comunidad). Report to the Community2018 02/26/2019. Available from: https://seamar.org/seamar-downloads/Annual-Report2018.pdf
- Coronado GD, Golovaty I, Longton G, Levy L, Jimenez R. Effectiveness of a clinic-based colorectal cancer screening promotion program for underserved Hispanics. Cancer. 2011 Apr 15;117(8):1745-54. doi: 10.1002/cncr.25730. Epub 2010 Nov 8.
- Parker E, Margolis LH, Eng E, Henriquez-Roldan C. Assessing the capacity of health departments to engage in community-based participatory public health. Am J Public Health. 2003 Mar;93(3):472-6. doi: 10.2105/ajph.93.3.472.
- Thompson B, Coronado G, Snipes SA, Puschel K. Methodologic advances and ongoing challenges in designing community-based health promotion programs. Annu Rev Public Health. 2003;24:315-40. doi: 10.1146/annurev.publhealth.24.100901.140819. Epub 2001 Nov 6.
- University of Washington. Developing and Sustaining Community Based Participatory Research Partnerships: A Skill Building Curriculum2012 04/21/2012 Available from: http://depts.washington.edu/ccph/cbpr/u1/u11.php.
- University of Washington School of Public Health and Community Medicine. Community-based research principles. Available from: http://sphcm.washington.edu/research/community.htm.
- Byrd TL, Wilson KM, Smith JL, Coronado G, Vernon SW, Fernandez-Esquer ME, Thompson B, Ortiz M, Lairson D, Fernandez ME. AMIGAS: a multicity, multicomponent cervical cancer prevention trial among Mexican American women. Cancer. 2013 Apr 1;119(7):1365-72. doi: 10.1002/cncr.27926. Epub 2012 Dec 21.
- Thompson B, Carosso EA, Jhingan E, Wang L, Holte SE, Byrd TL, Benavides MC, Lopez C, Martinez-Gutierrez J, Ibarra G, Gonzalez VJ, Gonzalez NE, Duggan CR. Results of a randomized controlled trial to increase cervical cancer screening among rural Latinas. Cancer. 2017 Feb 15;123(4):666-674. doi: 10.1002/cncr.30399. Epub 2016 Oct 27.
- Duggan C, Coronado G, Martinez J, Byrd TL, Carosso E, Lopez C, Benavides M, Thompson B. Cervical cancer screening and adherence to follow-up among Hispanic women study protocol: a randomized controlled trial to increase the uptake of cervical cancer screening in Hispanic women. BMC Cancer. 2012 May 6;12:170. doi: 10.1186/1471-2407-12-170.
- Coronado GD, Rivelli JS, Fuoco MJ, Vollmer WM, Petrik AF, Keast E, Barker S, Topalanchik E, Jimenez R. Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches. J Gen Intern Med. 2018 Jan;33(1):72-78. doi: 10.1007/s11606-017-4184-x. Epub 2017 Oct 10.
- Kepka DL, Ulrich AK, Coronado GD. Low knowledge of the three-dose HPV vaccine series among mothers of rural Hispanic adolescents. J Health Care Poor Underserved. 2012 May;23(2):626-35. doi: 10.1353/hpu.2012.0040.
- Kepka DL, Coronado GD, Rodriguez HP, Thompson B. Development of a radionovela to promote HPV vaccine awareness and knowledge among Latino parents. Public Health Rep. 2012 Jan-Feb;127(1):130-8. doi: 10.1177/003335491212700118. No abstract available.
- Ayres S, Gee A, Kim S, Hashibe M, Praag A, Kaiser D, Chang CP, Brandt HM, Kepka D. Human Papillomavirus Vaccination Knowledge, Barriers, and Recommendations Among Healthcare Provider Groups in the Western United States. J Cancer Educ. 2022 Dec;37(6):1816-1823. doi: 10.1007/s13187-021-02047-6. Epub 2021 Jul 8.
- Brandt HM, Kepka D, Kirchhoff AC, Daniel CL, Bhatt NS. Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors. Cancer. 2022 Jan 15;128(2):237-239. doi: 10.1002/cncr.33920. Epub 2021 Oct 4.
- Kepka D, Christini K, McGough E, Wagner A, Del Fiol G, Gibson B, Ayres S, Brandt HM, Mann S, Petrik AF, Coronado GD. Successful Multi-Level HPV Vaccination Intervention at a Rural Healthcare Center in the Era of COVID-19. Front Digit Health. 2021 Aug 19;3:719138. doi: 10.3389/fdgth.2021.719138. eCollection 2021.
- Kepka D, Ding Q, Bodson J, Warner EL, Mooney K. Latino Parents' Awareness and Receipt of the HPV Vaccine for Sons and Daughters in a State with Low Three-Dose Completion. J Cancer Educ. 2015 Dec;30(4):808-12. doi: 10.1007/s13187-014-0781-0.
- Warner EL, Lai D, Carbajal-Salisbury S, Garza L, Bodson J, Mooney K, Kepka D. Latino Parents' Perceptions of the HPV Vaccine for Sons and Daughters. J Community Health. 2015 Jun;40(3):387-94. doi: 10.1007/s10900-014-9949-0.
- Kepka D, Warner EL, Kinney AY, Spigarelli MG, Mooney K. Low human papillomavirus (HPV) vaccine knowledge among Latino parents in Utah. J Immigr Minor Health. 2015 Feb;17(1):125-31. doi: 10.1007/s10903-014-0003-1.
- Warner EL, Ding Q, Pappas LM, Henry K, Kepka D. White, affluent, educated parents are least likely to choose HPV vaccination for their children: a cross-sectional study of the National Immunization Study - teen. BMC Pediatr. 2017 Dec 1;17(1):200. doi: 10.1186/s12887-017-0953-2.
- Islam JY, Gruber JF, Kepka D, Kunwar M, Smith SB, Rothholz MC, Brewer NT, Smith JS. Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States. Hum Vaccin Immunother. 2019;15(7-8):1839-1850. doi: 10.1080/21645515.2018.1556077. Epub 2019 Feb 6.
- Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, Fredua B, McNamara L, Stokley S. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109-1116. doi: 10.15585/mmwr.mm6933a1.
- Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Winawer SJ, Habbema JD, Zauber AG. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer. 2006 Oct 1;107(7):1624-33. doi: 10.1002/cncr.22115.
- Hopfer S, Garcia S, Duong HT, Russo JA, Tanjasiri SP. A Narrative Engagement Framework to Understand HPV Vaccination Among Latina and Vietnamese Women in a Planned Parenthood Setting. Health Educ Behav. 2017 Oct;44(5):738-747. doi: 10.1177/1090198117728761. Epub 2017 Aug 30.
- Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011 Jun;165(6):547-53. doi: 10.1001/archpediatrics.2011.73.
- Vanderpool RC, Stradtman LR, Brandt HM. Policy opportunities to increase HPV vaccination in rural communities. Hum Vaccin Immunother. 2019;15(7-8):1527-1532. doi: 10.1080/21645515.2018.1553475. Epub 2019 Jan 4.
- Brandt HM, Pierce JY, Crary A. Increasing HPV vaccination through policy for public health benefit. Hum Vaccin Immunother. 2016 Jun 2;12(6):1623-5. doi: 10.1080/21645515.2015.1122145. Epub 2015 Dec 15.
- Khuwaja SS, Peck JL. Increasing HPV Vaccination Rates Using Text Reminders: An Integrative Review of the Literature. J Pediatr Health Care. 2022 Jul-Aug;36(4):310-320. doi: 10.1016/j.pedhc.2022.02.001. Epub 2022 Mar 11.
- Francis DB, Cates JR, Wagner KPG, Zola T, Fitter JE, Coyne-Beasley T. Communication technologies to improve HPV vaccination initiation and completion: A systematic review. Patient Educ Couns. 2017 Jul;100(7):1280-1286. doi: 10.1016/j.pec.2017.02.004. Epub 2017 Feb 6.
- Hou SI, Fernandez ME, Parcel GS. Development of a cervical cancer educational program for Chinese women using intervention mapping. Health Promot Pract. 2004 Jan;5(1):80-7. doi: 10.1177/1524839903257311.
- Byrd TL, Wilson KM, Smith JL, Heckert A, Orians CE, Vernon SW, Fernandez-Esquer ME, Fernandez ME. Using intervention mapping as a participatory strategy: development of a cervical cancer screening intervention for Hispanic women. Health Educ Behav. 2012 Oct;39(5):603-11. doi: 10.1177/1090198111426452. Epub 2012 Mar 1.
- Fernandez ME, Gonzales A, Tortolero-Luna G, Partida S, Bartholomew LK. Using intervention mapping to develop a breast and cervical cancer screening program for Hispanic farmworkers: Cultivando La Salud. Health Promot Pract. 2005 Oct;6(4):394-404. doi: 10.1177/1524839905278810.
- Warner EL, Fowler B, Martel L, Kepka D. Improving HPV Vaccination Through a Diverse Multi-state Coalition. J Community Health. 2017 Oct;42(5):911-920. doi: 10.1007/s10900-017-0334-7.
- Paskett ED, Krok-Schoen JL, Pennell ML, Tatum CM, Reiter PL, Peng J, Bernardo BM, Weier RC, Richardson MS, Katz ML. Results of a Multilevel Intervention Trial to Increase Human Papillomavirus (HPV) Vaccine Uptake among Adolescent Girls. Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):593-602. doi: 10.1158/1055-9965.EPI-15-1243.
- Fridman A, Gershon R, Gneezy A. COVID-19 and vaccine hesitancy: A longitudinal study. PLoS One. 2021 Apr 16;16(4):e0250123. doi: 10.1371/journal.pone.0250123. eCollection 2021.
- Santibanez TA, Singleton JA, Santibanez SS, Wortley P, Bell BP. Socio-demographic differences in opinions about 2009 pandemic influenza A (H1N1) and seasonal influenza vaccination and disease among adults during the 2009-2010 influenza season. Influenza Other Respir Viruses. 2013 May;7(3):383-92. doi: 10.1111/j.1750-2659.2012.00374.x. Epub 2012 May 9.
- Arda B, Durusoy R, Yamazhan T, Sipahi OR, Tasbakan M, Pullukcu H, Erdem E, Ulusoy S. Did the pandemic have an impact on influenza vaccination attitude? A survey among health care workers. BMC Infect Dis. 2011 Apr 7;11:87. doi: 10.1186/1471-2334-11-87.
- Halperin BA, MacKinnon-Cameron D, McNeil S, Kalil J, Halperin SA. Maintaining the momentum: key factors influencing acceptance of influenza vaccination among pregnant women following the H1N1 pandemic. Hum Vaccin Immunother. 2014;10(12):3629-41. doi: 10.4161/21645515.2014.980684.
- Quinn SC, Parmer J, Freimuth VS, Hilyard KM, Musa D, Kim KH. Exploring communication, trust in government, and vaccination intention later in the 2009 H1N1 pandemic: results of a national survey. Biosecur Bioterror. 2013 Jun;11(2):96-106. doi: 10.1089/bsp.2012.0048. Epub 2013 Apr 25.
- Meyer AF, Borkovskiy NL, Brickley JL, Chaudhry R, Franqueira A, Furst JW, Hinsch DM, McDonah MR, Myers JF, Petersen RE, Finney Rutten LJ, Wilson PM, Jacobson RM. Impact of Electronic Point-of-Care Prompts on Human Papillomavirus Vaccine Uptake in Retail Clinics. Am J Prev Med. 2018 Dec;55(6):822-829. doi: 10.1016/j.amepre.2018.06.027. Epub 2018 Oct 19.
- Henrikson NB, Zhu W, Baba L, Nguyen M, Berthoud H, Gundersen G, Hofstetter AM. Outreach and Reminders to Improve Human Papillomavirus Vaccination in an Integrated Primary Care System. Clin Pediatr (Phila). 2018 Nov;57(13):1523-1531. doi: 10.1177/0009922818787868. Epub 2018 Jul 13.
- Larson HJ, Clarke RM, Jarrett C, Eckersberger E, Levine Z, Schulz WS, Paterson P. Measuring trust in vaccination: A systematic review. Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609. doi: 10.1080/21645515.2018.1459252. Epub 2018 May 10.
- Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, De Angelis S, Takacs J, Ali KA, Pastore Celentano L, Larson H. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccin Immunother. 2019;15(7-8):1615-1627. doi: 10.1080/21645515.2018.1564436. Epub 2019 Feb 20.
- Succi RCM. Vaccine refusal - what we need to know. J Pediatr (Rio J). 2018 Nov-Dec;94(6):574-581. doi: 10.1016/j.jped.2018.01.008. Epub 2018 Apr 12.
- Saxena K, Marden JR, Carias C, Bhatti A, Patterson-Lomba O, Gomez-Lievano A, Yao L, Chen YT. Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States. Curr Med Res Opin. 2021 Dec;37(12):2077-2087. doi: 10.1080/03007995.2021.1981842. Epub 2021 Oct 4.
- Ryan G, Gilbert PA, Ashida S, Charlton ME, Scherer A, Askelson NM. Challenges to Adolescent HPV Vaccination and Implementation of Evidence-Based Interventions to Promote Vaccine Uptake During the COVID-19 Pandemic: "HPV Is Probably Not at the Top of Our List". Prev Chronic Dis. 2022 Mar 31;19:E15. doi: 10.5888/pcd19.210378.
- Patel Murthy B, Zell E, Kirtland K, Jones-Jack N, Harris L, Sprague C, Schultz J, Le Q, Bramer CA, Kuramoto S, Cheng I, Woinarowicz M, Robison S, McHugh A, Schauer S, Gibbs-Scharf L. Impact of the COVID-19 Pandemic on Administration of Selected Routine Childhood and Adolescent Vaccinations - 10 U.S. Jurisdictions, March-September 2020. MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):840-845. doi: 10.15585/mmwr.mm7023a2.
- Santoli JM, Lindley MC, DeSilva MB, Kharbanda EO, Daley MF, Galloway L, Gee J, Glover M, Herring B, Kang Y, Lucas P, Noblit C, Tropper J, Vogt T, Weintraub E. Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):591-593. doi: 10.15585/mmwr.mm6919e2.
- Ateev Mehrotra et al., The Impact of COVID-19 on Outpatient Visits in 2020: Visits Remained Stable, Despite a Late Surge in Cases (Commonwealth Fund, Feb. 2021)
- Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). For Healthcare Professionals. Preserve Supplies. https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhealthcare-facilities%2Findex.html
- Mann S, Christini K, Chai Y, Chang CP, Hashibe M, Kepka D. Vaccine hesitancy and COVID-19 immunization among rural young adults. Prev Med Rep. 2022 Aug;28:101845. doi: 10.1016/j.pmedr.2022.101845. Epub 2022 Jun 2.
- Bar-On YM, Flamholz A, Phillips R, Milo R. SARS-CoV-2 (COVID-19) by the numbers. Elife. 2020 Apr 2;9:e57309. doi: 10.7554/eLife.57309.
- Piltch-Loeb R, Silver DR, Kim Y, Norris H, McNeill E, Abramson DM. Determinants of the COVID-19 vaccine hesitancy spectrum. PLoS One. 2022 Jun 1;17(6):e0267734. doi: 10.1371/journal.pone.0267734. eCollection 2022.
- Williams CL, Walker TY, Elam-Evans LD, Yankey D, Fredua B, Saraiya M, Stokley S. Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, National Immunization Survey-Teen, 2016-2017. Hum Vaccin Immunother. 2020 Mar 3;16(3):562-572. doi: 10.1080/21645515.2019.1670036. Epub 2019 Oct 25.
- Uva JL, Wagner VL, Gesten FC. Emergency department reliance among rural children in Medicaid in New York State. J Rural Health. 2012 Spring;28(2):152-61. doi: 10.1111/j.1748-0361.2011.00377.x. Epub 2011 Apr 27.
- DeGuzman PB, Huang G, Lyons G, Snitzer J, Keim-Malpass J. Rural Disparities in Early Childhood Well Child Visit Attendance. J Pediatr Nurs. 2021 May-Jun;58:76-81. doi: 10.1016/j.pedn.2020.12.005. Epub 2020 Dec 25.
- Zablotsky B, Black LI. Prevalence of Children Aged 3-17 Years With Developmental Disabilities, by Urbanicity: United States, 2015-2018. Natl Health Stat Report. 2020 Feb;(139):1-7.
- Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, Singleton JA, Stokley S. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):718-723. doi: 10.15585/mmwr.mm6833a2.
- Glenn BA, Tsui J, Coronado GD, Fernandez ME, Savas LS, Taylor VM, Bastani R. Understanding HPV vaccination among Latino adolescent girls in three U.S. regions. J Immigr Minor Health. 2015 Feb;17(1):96-103. doi: 10.1007/s10903-014-9996-8.
- Mohammed KA, Subramaniam DS, Geneus CJ, Henderson ER, Dean CA, Subramaniam DP, Burroughs TE. Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med. 2018 Apr;109:39-43. doi: 10.1016/j.ypmed.2018.01.016. Epub 2018 Jan 31.
- Shell R, Tudiver F. Barriers to cancer screening by rural Appalachian primary care providers. J Rural Health. 2004 Fall;20(4):368-73. doi: 10.1111/j.1748-0361.2004.tb00051.x.
- Peterson CE, Silva A, Holt HK, Balanean A, Goben AH, Dykens JA. Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review. Cancer Causes Control. 2020 Sep;31(9):801-814. doi: 10.1007/s10552-020-01323-y. Epub 2020 Jun 14.
- Casey MM, Thiede Call K, Klingner JM. Are rural residents less likely to obtain recommended preventive healthcare services? Am J Prev Med. 2001 Oct;21(3):182-8. doi: 10.1016/s0749-3797(01)00349-x.
- Yabroff KR, Lawrence WF, King JC, Mangan P, Washington KS, Yi B, Kerner JF, Mandelblatt JS. Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment? J Rural Health. 2005 Spring;21(2):149-57. doi: 10.1111/j.1748-0361.2005.tb00075.x.
- Koopman RJ, Mainous AG 3rd, Geesey ME. Rural residence and Hispanic ethnicity: doubly disadvantaged for diabetes? J Rural Health. 2006 Winter;22(1):63-8. doi: 10.1111/j.1748-0361.2006.00009.x.
- United States Department of Agriculture. Rural America At a Glance: 2018 Edition. Economic Research Service. Economic Information Bulletin 200. November 2018.
- Newcomer SR, Freeman RE, Albers AN, Murgel S, Thaker J, Rechlin A, Wehner BK. Missed opportunities for human papillomavirus vaccine series initiation in a large, rural U.S. state. Hum Vaccin Immunother. 2022 Jan 31;18(1):2016304. doi: 10.1080/21645515.2021.2016304. Epub 2022 Feb 4.
- Centers for Disease Control and Prevention. Human Papillomavirus (HPV). Cancers Caused by HPV. . Available from: https://www.cdc.gov/hpv/parents/cancer.html
- Centers for Disease Control and Prevention. HPV-Associated Cancers Rates by Race and Ethnicity. 2019. Atlanta
- Vanderpool RC, Dressler EV, Stradtman LR, Crosby RA. Fatalistic beliefs and completion of the HPV vaccination series among a sample of young Appalachian Kentucky women. J Rural Health. 2015 Spring;31(2):199-205. doi: 10.1111/jrh.12102. Epub 2015 Jan 14.
- Blumling AA, Thomas TL, Stephens DP. Researching and Respecting the Intricacies of Isolated Communities. Online J Rural Nurs Health Care. 2013;13(2):Blumling.
- Head KJ, Vanderpool RC, Mills LA. Health care providers' perspectives on low HPV vaccine uptake and adherence in Appalachian Kentucky. Public Health Nurs. 2013 Jul;30(4):351-60. doi: 10.1111/phn.12044. Epub 2013 Apr 8.
- Centers for Disease Control and Prevention. TeenVaxView. Vaccination Coverage among Adolescents (13 - 17 Years). . Available from: https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/index.html
- U.S. Department of Health and Human Services. Office of Disease Prevention and Health Promotion. Healthy People 2030. Increase the proportion of adolescents who get recommended doses of the HPV vaccine - IID-08. Available from: https://health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/increase-proportion-adolescents-who-get-recommended-doses-hpv-vaccine-iid-08.
- Centers for Disease Control and Prevention. How Many Cancers Are Linked with HPV Each Year? Available from: https://www.cdc.gov/cancer/hpv/statistics/cases.htm.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
2. februar 2024
Primær færdiggørelse (Faktiske)
1. marts 2024
Studieafslutning (Faktiske)
31. marts 2024
Datoer for studieregistrering
Først indsendt
4. februar 2024
Først indsendt, der opfyldte QC-kriterier
29. februar 2024
Først opslået (Faktiske)
4. marts 2024
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
18. maj 2025
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
1. maj 2025
Sidst verificeret
1. maj 2025
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
- Teenager
- Mennesker
- Barn
- Motivering
- Vaccination
- Forekomst
- Kvinde
- Han
- Forældre
- Omsorgspersoner
- Meddelelse
- Randomiseret kontrolforsøg
- Papillomavirusvacciner
- Tekstbeskeder
- Papillomavirus infektioner
- Kvalitativ forskning
- Religion
- Patientaccept af sundhedsvæsen
- Sundhedspersonale
- Sundhedsviden, holdninger, praksis
- Undersøgelser og spørgeskemaer
- Participatorisk tilgang
- Forenede Stater
- Hispanic eller Latino
- Interessenters deltagelse
- Landbefolkning
- Sociale normer
- Religiøsitet
- Papillomavirus Vacciner / administration & dosering
- Humant papillomavirus vira
- Papillomavirus infektioner / forebyggelse og kontrol
- Kræft / forebyggelse & kontrol
- Påmindelsessystemer / instrumentering
- Vaccinationsafslag
- Sundhedsfremme/metoder
- Forældre/uddannelse
- Kvantitativ forskning
Andre undersøgelses-id-numre
- HCI161649-1
- 1R01CA279973-01 (U.S. NIH-bevilling/kontrakt)
- DSS_10065815 (Anden identifikator: University of Utah, Document Summary Sheet (DSS) Number)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
UBESLUTET
IPD-planbeskrivelse
En plan for deling af IDP, der opretholder deltagernes anonymitet, er endnu ikke blevet udviklet.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med HPV-vaccination
-
Xiamen UniversityXiamen Innovax Biotech Co., Ltd; Xiamen Center for Disease Control and...Ikke rekrutterer endnuHPV-vaccinationsrater | HPV-vaccinebevidsthed | Intention om HPV-vaccination
-
Michigan State UniversityRekrutteringHPV-vaccinationForenede Stater
-
Anne E RayReal Prevention, LLC; Merck Institute for Therapeutic ResearchIkke rekrutterer endnu
-
Memorial Sloan Kettering Cancer CenterHackensack Meridian Health; The City College of New YorkAktiv, ikke rekrutterendeForsøg med en social marketingkampagne for at øge HPV-vaccination blandt mexicanske amerikanske børnHPV-vaccinationForenede Stater
-
Yale UniversityNational Cancer Institute (NCI)Afsluttet
-
Yasemin ATEŞEYANAfsluttet
-
Xiamen UniversityXiamen Center for Disease Control and PreventionIkke rekrutterer endnuHPV-vaccinationsrater | HPV-vaccinebevidsthed | Intention om HPV-vaccination
-
University of Alabama at BirminghamAktiv, ikke rekrutterendeHPV-vaccinationForenede Stater
-
Michigan State UniversityRekruttering
-
JhpiegoRekrutteringTeenager | Integreret pleje | HPV-vaccinationCôte D'Ivoire
Kliniske forsøg med FOREBYG - BCT
-
University of ArizonaNational Cancer Institute (NCI); National Institutes of Health (NIH)RekrutteringBrystkræftForenede Stater
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)RekrutteringDepression | Selvmordstanker | Selvmord, ForsøgForenede Stater
-
Regen Lab SAAfsluttet
-
Metabiomics CorpSuspenderetKolorektal cancer | Kolorektalt adenomForenede Stater
-
Bio-Cancer Treatment International LimitedUkendt
-
Réseau Sep Idf OuestAfsluttetTræthed | Recidiverende remitterende multipel sklerose | Kognitiv terapiFrankrig
-
IRCCS Policlinico S. MatteoAfsluttet
-
Edinburgh Napier UniversityUniversity of Dundee; The University of New South Wales; University of Aberdeen og andre samarbejdspartnereUkendtAkut koronarsyndromDet Forenede Kongerige
-
University of BirminghamAfsluttetKræft | Pædiatrisk ALT | Pædiatrisk solid tumor | Pædiatrisk AMLDet Forenede Kongerige, Australien, Holland